<DOC>
	<DOCNO>NCT00873015</DOCNO>
	<brief_summary>The purpose study examine safety 14 day infusion sodium nitrite , study pharmacokinetics nitrite , 14 day infusion patient rupture cerebral aneurysm .</brief_summary>
	<brief_title>Safety Pharmacokinetic Evaluation Nitrite Prevention Cerebral Vasospasm</brief_title>
	<detailed_description>Intravenous sodium nitrite show prevent reverse cerebral vasospasm primate model subarachnoid hemorrhage ( SAH ) . This Phase IIA dose escalation study sodium nitrite determine safety patient aneurysmal SAH establish pharmacokinetics 14 day infusion . Sodium nitrite deliver intravenously 14 day 18 patient SAH rupture cerebral aneurysm use dose escalation scheme three cohort 6 patient ( 3 nitrite , 3 saline ) , maximum dose 64 nmol/min/kg . Sodium nitrite blood level frequently sample measure use mass spectroscopy blood methemoglobin level continuously monitor use pulse oximeter .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<criteria>Ruptured cerebral aneurysm Pregnancy , sickle cell disease , G6PD deficiency , anticoagulant therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Cerebral aneurysm</keyword>
	<keyword>Subarachnoid hemorrhage</keyword>
	<keyword>Nitrite</keyword>
</DOC>